Company / Shares Outstanding
Bristol Myers Squibb Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
2.1B
FY2025
5-year range
1.7B / 2.3B
FY2021-FY2025
Trend
-3.2%
vs FY2024
Sector context
#5 of 212
Health Care
What the data says
Among 212 Health Care companies, Bristol Myers Squibb is in the bottom 2% for shares outstanding. Shares Outstanding has declined for 3 consecutive years, from 2258000000.00 in FY2022 to 2078000000.00 in FY2025.
Based on SEC 10-K filings.
2078000000.00 in FY2025 with a 5-year CAGR of +4.9%. Top quartile in the Health Care sector.
Improved from 2245000000.00 to 2078000000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -2.7%
- 5-Year CAGR
- +4.9%
- 10-Year CAGR
- -
Sector benchmark
+577.6% above sector average
Key checks
Key Insights
- Bristol Myers Squibb's shares outstanding has declined for 3 consecutive years.
- In FY2025, shares outstanding decreased 3.2% year-over-year.
- Ranks #5 out of 212 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2022.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 2.1B | -3.2% |
| FY2024 | 2.1B | -4.4% |
| FY2023 | 2.2B | -0.6% |
| FY2022 | 2.3B | +31.9% |
| FY2021 | 1.7B | +4.6% |
| FY2020 | 1.6B | -0.9% |
| FY2019 | 1.7B | -1.7% |
| FY2018 | 1.7B | +0.1% |
| FY2017 | 1.7B | +0.5% |
| FY2016 | 1.7B | +0.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026